4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0001209191-16-142261
Pres. & Chief Executive Offic sold 1,972 shares at $2.89 ($5,699)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BRISTOW MICHAEL R Pres. & Chief Executive Offic | 2016-09-20 | Sale | −1,972 | $2.89 | $5,699 | 42,638 | D: show line 1 in the form |
| Open-market sales · 1,972 sh · avg $2.89 · $5,699 | |||||||
Loading xslF345X03/doc4.xml…